Paramedic PapersHome Trauma Fibrinogen concentrate supply grows in Queensland
Trauma
Fibrinogen concentrate supply grows in Queensland
Supply of Fibrinogen Concentrate Across Queensland Health
Emergency Medicine Australasia · 2026-11-09 · Added 11 November 2026
A ten-year Queensland Health supply analysis of 24,717 g of fibrinogen concentrate found 97% went to 54 hospitals and only 1% to ambulance services, while population-adjusted supply rose from 8.19 to 59.2 g per 100,000 between 2016 and 2025.
- Study type
- Other
- Design
- Retrospective statewide supply analysis
- Participants
- 24,717 g of fibrinogen concentrate supplied across Queensland, 2016–2026
- Main finding
- 97.0% of supply went to 54 hospitals, 2.0% to retrieval services and 1.0% to ambulance services; 66.2% went to major trauma services and 92.9% to viscoelastic-assay-capable hospitals; population-adjusted supply rose from 8.19 to 59.2 g per 100,000 (2016–2025)
- Caveat
- Supply data only — no patient outcomes, no link to bleeding control or mortality
- Bottom line
- Context only
Why it matters in Australia (Medium relevance). Fibrinogen concentrate isn't carried by Australian ambulances, so this is supply-chain context for the bleeding debate rather than current practice
Learning goal
Understand the supply pathways and access barriers that shape prehospital availability of fibrinogen concentrate in Australia.
More
- Topic: Trauma
- Daily scan: 11 November 2026
Related papers on Trauma
-
Sydney COAST registry: trauma shock first year
An Australian prospective multicentre registry enrolled 257 adults with prehospital trauma shock over 12 months in Sydney, finding hypotension drove 90% of shock definitions, 53% received prehospital blood, and mortality was 4.7% at 4 hours and 21% at 30 days.
-
Whole blood vs components: mixed mortality, lower transfusion needs
A PRISMA systematic review of 22 comparative studies (about 95,000 patients) on whole blood versus component therapy for trauma resuscitation found mixed mortality results — survival signals in hypotensive, penetrating and geriatric subgroups but not everywhere — with consistently lower transfusion requirements and comparable or better safety with whole blood.
-
Forecast: prehospital transfusion growth and HDFN risk
US researchers forecast that growing prehospital transfusion of RhD-positive blood to females of childbearing potential will lead to haemolytic disease of the fetus and newborn, with one predicted case every 0.5–20 years depending on region and model.
-
Physiology-based traumatic shock pathway rolled out
An Australian Level 1 trauma centre implemented a physiology-based traumatic shock pathway (SBP ≤ 90 mmHg, shock index > 1, prehospital blood or senior clinician concern) and post-implementation staff surveys rated the equipment, interventions and roles highly, though clinical effectiveness wasn't assessed.